Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-20 @ 5:31 PM
Study NCT ID:
NCT06480968
Status:
COMPLETED
Last Update Posted:
2025-01-23
First Post:
2023-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CTH120 First-in-Human Study: Single and Multiple Ascending Doses and Potential Food Interaction
Sponsor:
Connecta Therapeutics, S.L.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Fragile X Syndrome | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Fragile X Syndrome | View |
| None | FXS | View |
| None | Fragile X | View |
| None | Neurodevelopmental Disorders | View |
| None | Central Nervous System Diseases | View |
| None | Intellectual Disability | View |
| None | Neurobehavioral Manifestations | View |
| None | Genetic Diseases, X-Linked | View |
| None | Congenital Abnormalities | View |
| None | Orphan Diseases | View |
| None | Rare Diseases | View |